Agilent Technologies Announces New Leadership in Biological Systems Division
News Feb 17, 2010
Agilent Technologies Inc. has announced the appointments of Robert Schueren as vice president and general manager, Genomics; and John Fjeldsted, Ph.D., as general manager, Liquid Chromatography/Mass Spectrometry.
“The life sciences and biological systems business continues to be a key growth driver for Agilent, and the addition of Robert and John strengthens our current leadership team and positions us well for future success,” said Gustavo Salem, vice president and general manager of Agilent’s Biological Systems Division.
Schueren will be responsible for all genomics operations, including microarrays, QPCR and life science reagents. Most recently, he was global head of companion diagnostics, clinical biomarker, and sample operations at Genentech/Roche.
Fjeldsted will be responsible for managing the LC/MS business and driving market share in high-end LC/MS. He has been with Agilent for more than 25 years and played a key role in the tremendous growth of Agilent’s LC/MS unit.
Additionally, George Stafford has joined Agilent as LC/MS hardware R&D manager. Most recently, Stafford held the position of R&D program manager, responsible for Thermo Fisher Scientific’s LC/MS research programs and university collaborations.
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Engineering the Gut Microbiome with 'Good' Bacteria May Help Treat Crohn's DiseaseNews
Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. Replacement of the offending bacteria with "good" bacteria may offer an effective treatment approach.READ MORE
New Player in Alzheimer's Disease Pathogenesis IdentifiedNews
Using proteomics, microscopic analysis, and functional assays, scientists have shown that a protein called membralin is critical for keeping Alzheimer’s disease pathology in check.READ MORE